FRANCISCO JAVIER
MICHEL DE LA ROSA
Forscher bis um 2022
Hospital Costa Del Sol
Marbella, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Costa Del Sol (2)
2023
-
First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma
Journal of Investigational Allergology and Clinical Immunology
2018
-
Cost of hospitalizations due to exacerbation in patients with non-cystic fibrosis bronchiectasis
Respiration, Vol. 96, Núm. 5, pp. 406-416